Drugs to Watch 2020
Market intelligence reports
BioWorld - Thursday, April 2, 2020
» Completed and pending biopharma IPOs in February 2020
Looking to read the full article? Subscribe to BioWorld.
Completed and pending biopharma IPOs in February 2020
March 6, 2020
Completed and pending initial public offerings by biopharma companies, including: 4D Molecular, Akeso, Beam, Bio-Thera, Continent, Frontier, Hutchison China Meditech, Imara, Immunotech, Innocare, NLS, Oric, Passage Bio, Revolution Medicines, Scilex, Shanghai Shenlian, Tasly.
Analysis and data insight
Already a subscriber?